Richard D. Barker
- Chemical Health and Safety top 5%
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 12
- COVID-19 Clinical Research Studies 5
- Internal Medicine top 10%
- Dermatology top 10%
-
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- Diagnosis and treatment of tuberculosis 7
- Infectious Diseases and Tuberculosis 4
-
- COVID-19 and healthcare impacts 6
-
- Occupational exposure and asthma 5
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Co-authors
- Serge De VallièreA J Newman TaylorJessica HarrisF J MillardK. GardinerK M VenablesMartie van TongerenWO Cookson
- Journals
- European Respiratory Journal (3 papers)Journal of Allergy and Clinical Immunology (2 papers)Occupational and Environmental Medicine (2 papers)
- Partner nations
- United KingdomUnited StatesZimbabwe
In The Last Decade
Richard D. Barker
33 papers receiving 727 citations
Peers
Comparison fields: 5 of 98
- Chemical Health and Safety 17
- Infectious Diseases 354
- Internal Medicine 36
- Dermatology 69
- Epidemiology 235
Countries citing papers authored by Richard D. Barker
This map shows the geographic impact of Richard D. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Barker more than expected).
Fields of papers citing papers by Richard D. Barker
This network shows the impact of papers produced by Richard D. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Barker. The network helps show where Richard D. Barker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard D. Barker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2022 | 15 | |
| 3 | 2021 | 6 | |
| 4 | 2020 | 127 | |
| 5 | 2020 | 5 | |
| 6 | 2014 | 1 | |
| 7 | 2013 | 31 | |
| 8 | 2013 | 36 | |
| 9 | 2012 | 92 | |
| 10 | 2010 | 39 | |
| 11 | 2009 | 1 | |
| 12 | 2007 | 0 | |
| 13 | 2005 | 21 | |
| 14 | Residual lung damage after completion of treatment for multidrug-resistant tuberculosis. | 2004 | 47 |
| 15 | 2003 | 3 | |
| 16 | 2002 | 1 | |
| 17 | 2000 | 18 | |
| 18 | Occupational asthma caused by tetrachlorophthalic anhydride | 1998 | 1 |
| 19 | 1998 | 20 | |
| 20 | 1995 | 66 |
About Richard D. Barker
Richard D. Barker is a scholar working on Chemical Health and Safety, Infectious Diseases and Internal Medicine, having authored 36 papers that have together received 772 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (12 papers), Diagnosis and treatment of tuberculosis (7 papers), COVID-19 and healthcare impacts (6 papers), COVID-19 Clinical Research Studies (5 papers), Occupational exposure and asthma (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Infectious Diseases and Tuberculosis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Chemical Health and Safety (17 citations), Infectious Diseases (354 citations) and Internal Medicine (36 citations). Richard D. Barker has collaborated with scholars based in United Kingdom, United States and Zimbabwe. Frequent co-authors include Serge De Vallière, A J Newman Taylor, Jessica Harris, F J Millard, K. Gardiner, K M Venables, Martie van Tongeren, WO Cookson, K Pile and R P Young. Their work appears in journals such as European Respiratory Journal, Journal of Allergy and Clinical Immunology, Occupational and Environmental Medicine, Thorax and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.